270 related articles for article (PubMed ID: 26284152)
21. Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real-life clinical practice in Taiwan.
Cho YT; Pao YC; Chu CY
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):41-9. PubMed ID: 26428436
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.
Balp MM; Vietri J; Tian H; Isherwood G
Patient; 2015 Dec; 8(6):551-8. PubMed ID: 26476961
[TBL] [Abstract][Full Text] [Related]
23. State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians' and patients' perspectives.
Rimoldi M; Rossi O; Rota N
BMJ Open; 2016 Oct; 6(10):e012378. PubMed ID: 27742625
[TBL] [Abstract][Full Text] [Related]
24. Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study.
Grieco T; Ambrosio L; Trovato F; Vitiello M; Demofonte I; Fanto M; Paolino G; Pellacani G
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407429
[TBL] [Abstract][Full Text] [Related]
25. A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria.
Friedman A; Kwatra SG; Yosipovitch G
Dermatol Ther (Heidelb); 2024 Jun; 14(6):1371-1387. PubMed ID: 38758422
[TBL] [Abstract][Full Text] [Related]
26. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
Zazzali JL; Kaplan A; Maurer M; Raimundo K; Trzaskoma B; Solari PG; Antonova E; Mendelson M; Rosén KE
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):370-377.e1. PubMed ID: 27424128
[TBL] [Abstract][Full Text] [Related]
27. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
[TBL] [Abstract][Full Text] [Related]
28. Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study.
Danilycheva I; Emelyanov A; Meshkova R; Ukhanova O; Abdrakhmanov A; Litvin L
Postepy Dermatol Alergol; 2022 Jun; 39(3):509-516. PubMed ID: 35950113
[TBL] [Abstract][Full Text] [Related]
29. Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.
Lima H; Gooderham M; Dutz J; Lynde C; Chapdelaine H; Ellis A; Gilbert M; Ho V; Papp K; Poulin Y; Sussman G
Allergy Asthma Clin Immunol; 2017; 13():38. PubMed ID: 28852410
[TBL] [Abstract][Full Text] [Related]
30. Corticosteroid-related toxicity in patients with chronic idiopathic urticariachronic spontaneous urticaria.
Ledford D; Broder MS; Antonova E; Omachi TA; Chang E; Luskin A
Allergy Asthma Proc; 2016 Nov; 37(6):458-465. PubMed ID: 27931301
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
32. Chronic idiopathic urticaria: treatment with omalizumab.
Naaman S; Sussman G
Skin Therapy Lett; 2014; 19(6):1-4. PubMed ID: 25807072
[TBL] [Abstract][Full Text] [Related]
33. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.
Thomsen SF; Pritzier EC; Anderson CD; Vaugelade-Baust N; Dodge R; Dahlborn AK; Vestergaard C
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1048-1055. PubMed ID: 28294420
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria.
Kanters TA; Thio HB; Hakkaart L
Br J Dermatol; 2018 Sep; 179(3):702-708. PubMed ID: 29476533
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.
Hide M; Park HS; Igarashi A; Ye YM; Kim TB; Yagami A; Roh J; Lee JH; Chinuki Y; Youn SW; Lee SK; Inomata N; Choi JH; Fukunaga A; Wang J; Matsushima S; Greenberg S; Khalil S
J Dermatol Sci; 2017 Jul; 87(1):70-78. PubMed ID: 28366435
[TBL] [Abstract][Full Text] [Related]
36. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
Liang SE; Hoffmann R; Peterson E; Soter NA
JAMA Dermatol; 2019 Jan; 155(1):90-95. PubMed ID: 30476976
[TBL] [Abstract][Full Text] [Related]
37. Dupilumab as Add-on Therapy for Management of Chronic Spontaneous Urticaria.
Kudlaty E; Newell P; Chovatiya R
J Clin Aesthet Dermatol; 2024 Jan; 17(1):10-12. PubMed ID: 38298750
[TBL] [Abstract][Full Text] [Related]
38. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.
Casale TB; Bernstein JA; Maurer M; Saini SS; Trzaskoma B; Chen H; Grattan CE; Gimenéz-Arnau A; Kaplan AP; Rosén K
J Allergy Clin Immunol Pract; 2015; 3(5):743-50.e1. PubMed ID: 26054553
[TBL] [Abstract][Full Text] [Related]
39. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
40. Comparative Study of Positive Versus Negative Autologous Serum Skin Test in Chronic Spontaneous Urticaria and its Treatment Outcome.
Kumar YH; Bhaskar S; Shankar K
N Am J Med Sci; 2016 Jan; 8(1):25-30. PubMed ID: 27011944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
